ViiV Healthcare
Colombia seeks to slash HIV drug costs by overriding ViiVās patent
Anika Sharma
Colombia has taken a significant step in response to a pricing dispute with GSK’s ViiV Healthcare regarding the HIV medication ...
GSK aims to boost HIV sales to Ā£7B with new drugs and launches
Anika Sharma
GSK is charting an optimistic course for its HIV business, buoyed by the success of its long-acting antiretroviral therapy, Cabenuva. ...
Patients prefer ViiV’s injectable HIV medication, according to a Switch research
SG Tylor
When ViiV Healthcare and Johnson & Johnson introduced their once-monthly injectable HIV treatment Cabenuva in 2021, they anticipated that patients ...
